Zindaclin

Zindaclin Logo

Zindaclin is an effective topical therapy for mild to moderate acne. Its once-a-day gel formulation improves patient compliance by combining patients’ preferred attributes. It also contains zinc, which helps to improve skin healing.

Topical therapies are first-line treatments for mild to moderate acne but they only work if they get used.1

Poor compliance and reduced efficacy are major issues for GPs and dermatologists treating teenagers with acne.2

But ease of therapy and simple dosing regimens have been shown to improve patient compliance.3

A randomised, single-centre cross over study was conducted to determine and compare patient preferences. Over 4 weeks, patients used each of 3 topical antibiotics for 1 week.2

The study showed that patients clearly preferred a gel formulation that could be applied with the fingers once a day and stored at room temperature over 18 months.2

  • Contains the active ingredient Clindamycin Phosphate
  • Simple once a day application
  • Reduces bacterial resistance
  • Improves skin healing
  • Regulates oil production in sebaceous glands to prevent clogging
  • Reduces inflammation and the appearance of acne
  • Not for use by children under the age of 12
  • Read the patient information leaflet carefully before use
  • Contains the active ingredient Clindamycin Phosphate
  • Simple once a day application
  • Reduces bacterial resistance
  • Improves skin healing
  • Regulates oil production in sebaceous glands to prevent clogging
  • Reduces inflammation and the appearance of acne
  • Not for use by children under the age of 12
  • Read the patient information leaflet carefully before use

References

Sawada Y, Sone K. Hydration and occlusion treatment for hypertrophic scars and keloids. Br J Plast Surg. 1992;45:599–603.

Fulton JE., Jr Silicone gel sheeting for the prevention and management of evolving hypertrophic and keloid scars. Dermatol Surg. 1995;21:947–51.

Mustoe TA, et al. International clinical recommendations on scar management. Plast Reconstr Surg. 2002;110:560–71.

Durani P, Bayat A. Levels of evidence for the treatment of keloid disease. J Plast Reconstr Aesthet Surg. 2008;61:4–17.